echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Include Azvudine Tablets in the Novel Coronavirus Pneumonia Diagnosis and Treatment Program

    Include Azvudine Tablets in the Novel Coronavirus Pneumonia Diagnosis and Treatment Program

    • Last Update: 2022-08-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    All provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps Health and Health Committees and Administration of Traditional Chinese Medicine:
     
    According to the approval opinion of the State Food and Drug Administration on the conditional approval of the registration application of Azvudine Tablets for the treatment of new coronavirus pneumonia, in order to further improve the antiviral treatment plan for new coronavirus pneumonia, the drug was included in the "New Coronavirus Pneumonia" after research.
    Pneumonia Diagnosis and Treatment Program (Ninth Edition)
    .
    details as follows:
     
    1.
    The name of the drug
     
    Azvudine tablets
    .
     
    2.
    Indications
     
    For the treatment of adult patients with common novel coronavirus pneumonia (COVID-19)
    .
     
    3.
    Usage and dosage
     
    Swallow whole tablet on an empty stomach, 5 mg each time, once a day, and the course of treatment should not exceed 14 days
    .
     
      Fourth, matters needing attention
     
      It is not recommended for use during pregnancy and lactation, and it should be used with caution in patients with moderate to severe hepatic and renal impairment
    .
     
      Before using this drug, you should read the "Azvudine Tablet Instructions" approved by the State Food and Drug Administration, and use the drug correctly according to the indications, usage and dosage specified in the instructions
    .
    Patients should take medication under the guidance of a physician
    .
    Before prescribing this drug, physicians should be familiar with the contraindications, adverse reactions , drug interactions, etc.
    , and inquire about the patient's drug allergy history in detail, so as to avoid the use of patients with contraindications
    .
    All localities should strictly follow the requirements of the "Administrative Measures for the Reporting and Monitoring of Adverse Drug Reaction", and do a good job in monitoring and reporting adverse drug reactions to ensure drug safety
    .
     
      General Office of the National Health Commission
     
    Office of   the State Administration of Traditional Chinese Medicine
     
      August 9, 2022
      All provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps Health and Health Committees and Administration of Traditional Chinese Medicine:
     
      According to the approval opinion of the State Food and Drug Administration on the conditional approval of the registration application of Azvudine Tablets for the treatment of new coronavirus pneumonia, in order to further improve the antiviral treatment plan for new coronavirus pneumonia, the drug was included in the "New Coronavirus Pneumonia" after research.
    Pneumonia Diagnosis and Treatment Program (Ninth Edition)
    .
    details as follows:
     
      1.
    The name of the drug
    1.
    Name of medicines and medicines
     
      Azvudine tablets
    .
     
      2.
    Indications
    2.
    Indications
     
      For the treatment of adult patients with common novel coronavirus pneumonia (COVID-19)
    .
     
      3.
    Usage and dosage
    3.
    Usage and dosage
     
      Swallow whole tablet on an empty stomach, 5 mg each time, once a day, and the course of treatment should not exceed 14 days
    .
     
      Fourth, matters needing attention
    Fourth, matters needing attention
     
      It is not recommended for use during pregnancy and lactation, and it should be used with caution in patients with moderate to severe hepatic and renal impairment
    .
     
      Before using this drug, you should read the "Azvudine Tablet Instructions" approved by the State Food and Drug Administration, and use the drug correctly according to the indications, usage and dosage specified in the instructions
    .
    Patients should take medication under the guidance of a physician
    .
    Before prescribing this drug, physicians should be familiar with the contraindications, adverse reactions , drug interactions, etc.
    , and inquire about the patient's drug allergy history in detail, so as to avoid the use of patients with contraindications
    .
    All localities should strictly follow the requirements of the "Administrative Measures for the Reporting and Monitoring of Adverse Drug Reaction", and do a good job in monitoring and reporting adverse drug reactions to ensure drug safety
    .
    adverse reaction adverse reaction
     
      General Office of the National Health Commission
    healthy and healthy
     
    Office of   the State Administration of Traditional Chinese Medicine
    Medicine and medicine
     
      August 9, 2022
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.